COVID-19 pandemic disruption on the management of tuberculosis treatment in Indonesia GJ Caren, D Iskandar, DAE Pitaloka, R Abdulah, AA Suwantika Journal of multidisciplinary healthcare, 175-183, 2022 | 58 | 2022 |
Docking-based virtual screening and molecular dynamics simulations of quercetin analogs as enoyl-acyl carrier protein reductase (InhA) inhibitors of Mycobacterium tuberculosis DAE Pitaloka, DSF Ramadhan, Arfan, L Chaidir, TM Fakih Scientia Pharmaceutica 89 (2), 20, 2021 | 33 | 2021 |
A narrative review of statin-induced rhabdomyolysis: molecular mechanism, risk factors, and management N Safitri, MF Alaina, DAE Pitaloka, R Abdulah Drug, healthcare and patient safety, 211-219, 2021 | 24 | 2021 |
Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: Recent updates and challenges JA Huang, IR Hartanti, MN Colin, DAE Pitaloka Digital Health 8, 20552076221100634, 2022 | 19 | 2022 |
Role of pharmacists in antimicrobial stewardship during COVID-19 outbreak: a scoping review IY Kusuma, H Pratiwi, DAE Pitaloka Journal of multidisciplinary healthcare, 2605-2614, 2022 | 11 | 2022 |
Omics biomarkers for monitoring tuberculosis treatment: a mini-review of recent insights and future approaches DAE Pitaloka, MRAAA Syamsunarno, R Abdulah, L Chaidir Infection and Drug Resistance, 2703-2711, 2022 | 11 | 2022 |
Regulation of mitogen-activated protein kinase signaling pathway and proinflammatory cytokines by ursolic acid in murine macrophages infected with Mycobacterium avium DAE Pitaloka, AM Cooper, AA Artarini, S Damayanti, EY Sukandar Infectious disease reports 12 (s1), 8717, 2020 | 9 | 2020 |
In vitro study of ursolic acid combination first-line antituberculosis drugs against drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis DAE Pitaloka, EY Sukandar Asian Journal of Pharmaceutical and Clinical Research, 216-218, 2017 | 9 | 2017 |
Molecular docking, dynamics simulation, and scanning electron microscopy (SEM) examination of clinically isolated mycobacterium tuberculosis by ursolic acid: A pentacyclic … DAE Pitaloka, S Damayanti, AA Artarini, EY Sukandar Indonesian Journal of Chemistry 19 (2), 328-336, 2019 | 8 | 2019 |
Synergistic study on n-hexane extract of Anredera cordifolia (Ten.) v Steenis (binahong) leaves combined with antituberculosis drugs against drug-sensitive and drug-resistant … DAE Pitaloka, EY Sukandar Journal of Applied Pharmaceutical Science 8 (5), 134-138, 2018 | 7 | 2018 |
Multi Epitope-Based Vaccine Design for Protection Against Mycobacterium tuberculosis and SARS-CoV-2 Coinfection DAE Pitaloka, A Izzati, SR Amirah, LA Syakuran Advances and Applications in Bioinformatics and Chemistry, 43-57, 2022 | 6 | 2022 |
Rasch modelling to assess psychometric validation of the Knowledge About Tuberculosis Questionnaire (KATUB-Q) for the general population in Indonesia IY Kusuma, DN Triwibowo, ADE Pratiwi, DAE Pitaloka International Journal of Environmental Research and Public Health 19 (24), 16753, 2022 | 5 | 2022 |
Herbal therapy for the treatment of seborrhea dermatitis R Mustarichie, T Rostinawati, DAE Pitaloka, NM Saptarini, Y Iskandar Clinical, Cosmetic and Investigational Dermatology, 2391-2405, 2022 | 5 | 2022 |
Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the pncA gene in clinical isolates of Mycobacterium tuberculosis DAE Pitaloka, A Arfan, DSF Ramadhan, L Chaidir Journal of Biomolecular Structure and Dynamics 42 (2), 759-765, 2024 | 3 | 2024 |
Discovery of potent triterpenoid and limonoid compounds targeting Mycobacterium tuberculosis enoyl acyl carrier protein reductase (InhA): An in silico investigation DAE Pitaloka, A Arfan, NM Alfarafisa, L Chaidir, U Supratman Informatics in Medicine Unlocked 40, 101299, 2023 | 2 | 2023 |
Network pharmacology to uncover potential anti-inflammatory and immunomodulatory constituents in Curcuma longa rhizome as complementary treatment in COVID-19 RB Indradi, DAE Pitaloka, S Suryani Pharmacia 69 (4), 995-1003, 2022 | 2 | 2022 |
Development and validation of assessment instrument for the perception and attitude toward tuberculosis among the general population in Indonesia: a Rasch analysis of … DAE Pitaloka, IY Kusuma, H Pratiwi, IS Pradipta Frontiers in Public Health 11, 1143120, 2023 | 1 | 2023 |
The assessment of Twitter discourse on the new COVID-19 variant, XBB. 1.5, through social network analysis IY Kusuma, H Pratiwi, SF Khairunnisa, DAE Pitaloka, AA Kurnianto Vaccine: X 14, 100322, 2023 | 1 | 2023 |
Multidrug-Resistant tuberculosis DA Wulandari, YW Hartati, AU Ibrahim, DAE Pitaloka Clinica Chimica Acta, 119701, 2024 | | 2024 |
Development and Validation of Questionnaire to Measure Parents’ Knowledge, Attitude, and Practice on Self-Medication of Children with Antibiotics in Bandung, Indonesia DAE Pitaloka, I Yuda Kusuma, A Insyirah, AN Oktariani, H Pratiwi, ... Infection and Drug Resistance, 6111-6120, 2023 | | 2023 |